Immunoreactivity of the fully humanized therapeutic antibody PankoMab-GEX™ is an independent prognostic marker for breast cancer patients

American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer

Harris, L. N., Fritsche, H. A., Mennel, R. G., Norton, L., Ravdin, P. M., Taube, S. E., Somerfield, M. R., Hayes, D. F., & Bast, R. C. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.2364 · Cited by 2,199 · see citing works

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)

McShane, L. M., Altman, D. G., Sauerbrei, W., Taube, S. E., Gion, M., & Clark, G. M. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji237 · Cited by 2,162 · see citing works

HER2 in Breast Cancer

Krishnamurti, U., & Silverman, J. F. (2014) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000015 · Cited by 329 · see citing works

Method for grading breast cancer.

Elston, E., & Ellis, I. O. (1993) · Journal of Clinical Pathology · doi:10.1136/jcp.46.2.189-b · Cited by 201 · see citing works

MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α

Wei, X., Xu, H., & Kufe, D. W. (2006) · Molecular Cell · doi:10.1016/j.molcel.2005.11.030 · Cited by 186 · see citing works

PankoMab: a potent new generation anti-tumour MUC1 antibody

Danielczyk, A., Stahn, R., Faulstich, D., Löffler, A., Märten, A., Karsten, U. R., & Goletz, S. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0135-9 · Cited by 127 · see citing works

Binding patterns of DTR-specific antibodies reveal a glycosylation-conditioned tumor-specific epitope of the epithelial mucin (MUC1)

Karsten, U. R. (2004) · Glycobiology · doi:10.1093/glycob/cwh090 · Cited by 109 · see citing works

Enhanced binding of antibodies to the DTR motif of MUC1 tandem repeat peptide is mediated by site-specific glycosylation.

Karsten, U. R., Diotel, C., Klich, G., et al. (1998) · PubMed · Cited by 94 · see citing works

c-Myc and Her2 cooperate to drive a stem-like phenotype with poor prognosis in breast cancer

Nair, R., Roden, D. L., Teo, W. S., McFarland, A., Junankar, S. R., Ye, S., Nguyen, A., Yang, J. Y. H., Nikolić, I., Hui, M. N., et al. (2013) · Oncogene · doi:10.1038/onc.2013.368 · Cited by 92 · see citing works

Mucins (MUC1 and MUC3) of Gastrointestinal and Breast Epithelia Reveal Different and Heterogeneous Tumor-associated Aberrations in Glycosylation

Cao, Y., Blohm, D. H., Ghadimi, B. M., et al. (1997) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549704501111 · Cited by 80 · see citing works

Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival

Lenhard, M., Lennerová, T., Heublein, S., et al. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-553 · Cited by 78 · see citing works

What Makes MUC1 a Tumor Antigen?

Karsten, U. R., von Mensdorff‐Pouilly, S., & Goletz, S. (2005) · Tumor Biology · doi:10.1159/000086956 · Cited by 78 · see citing works

Randomized Phase II Trial of Letrozole plus Anti-MUC1 Antibody AS1402 in Hormone Receptor–Positive Locally Advanced or Metastatic Breast Cancer

Ibrahim, N. K., Yariz, K. O., Bondarenko, I., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1151 · Cited by 71 · see citing works

Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer

Lenhard, M., Tsvilina, A., Schumacher, L., et al. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-2 · Cited by 65 · see citing works

The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome of invasive ductal breast carcinoma

van der Vegt, B., de Roos, M. A. J., Peterse, J. L., et al. (2007) · Histopathology · doi:10.1111/j.1365-2559.2007.02757.x · Cited by 61 · see citing works

Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer

Burford, B., Gentry‐Maharaj, A., Graham, R. A., Allen, D., Pedersen, J. W., Nudelman, A. S., Blixt, O., Fourkala, E.-O., Bueti, D., Dawnay, A., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.214 · Cited by 55 · see citing works

Thomsen-Friedenreich Antigen: The “Hidden” Tumor Antigen

Goletz, S., Cao, Y., Danielczyk, A., Ravn, P., Schöber, U., & Karsten, U. R. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0065-0_10 · Cited by 44 · see citing works

Reactivity of a humanized antibody (hPankoMab) towards a tumor-related MUC1 epitope (TA-MUC1) with various human carcinomas

Fan, X.-N., Karsten, U. R., Goletz, S., et al. (2010) · Pathology - Research and Practice · doi:10.1016/j.prp.2010.03.006 · Cited by 43 · see citing works

Clinical significance of subcellular localization of KL-6 mucin in primary colorectal adenocarcinoma and metastatic tissues

Guo, Q., Tang, W., Inagaki, Y., et al. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i1.54 · Cited by 38 · see citing works

Natural and Induced Humoral Responses to MUC1

von Mensdorff‐Pouilly, S., Moreno, M., & Verheijen, R. H. M. (2011) · Cancers · doi:10.3390/cancers3033073 · Cited by 34 · see citing works

Evaluation of a Novel Anti-Mucin 1 (MUC1) Antibody (PankoMab) as a Potential Diagnostic Tool in Human Ductal Breast Cancer; Comparison with Two Established Antibodies

Dian, D., Janni, W. J., Kühn, C., et al. (2009) · Oncology Research and Treatment · doi:10.1159/000209280 · Cited by 29 · see citing works

MUC1c Regulates Cell Survival in Pancreatic Cancer by Preventing Lysosomal Permeabilization

Banerjee, S., Mujumdar, N. R., Dudeja, V., MacKenzie, T. N., Krosch, T. C. K., Sangwan, V., Vickers, S. M., & Saluja, A. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043020 · Cited by 28 · see citing works

Multicentric and multifocal versusunifocal breast cancer: differences in the expression of E-cadherin suggest differences in tumor biology

Weissenbacher, T. M., Hirte, E., Kühn, C., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-361 · Cited by 28 · see citing works

TA-MUC1 epitope in non-small cell lung cancer

Kuemmel, A., Single, K., Bittinger, F., et al. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2008.04.005 · Cited by 26 · see citing works

MUC1 expression in canine malignant mammary tumours and relationship to clinicopathological features

Oliveira, J., Pinho, S. S., de Matos, A., et al. (2008) · The Veterinary Journal · doi:10.1016/j.tvjl.2008.09.007 · Cited by 24 · see citing works

Breast cancer humoral immune response: involvement of Lewis y through the detection of circulating immune complexes and association with Mucin 1 (MUC1)

Larrain, M. I., Demichelis, S. O., Crespo, M., et al. (2009) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-28-121 · Cited by 24 · see citing works

AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor (EGFR), HER2, and HER3: preclinical activity in HER2 non-amplified inflammatory breast cancer models

Mu, Z., Klinowska, T. C. M., Dong, X., et al. (2014) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-33-47 · Cited by 24 · see citing works

EMA: A Differentiation Antigen Related to Node Metastatic Capacity of Breast Carcinomas

Luna-Moré, S., Rius, F., Weil, B., et al. (2001) · Pathology - Research and Practice · doi:10.1078/0344-0338-00055 · Cited by 22 · see citing works

Staining of MUC1 in ovarian cancer tissues with PankoMab-GEX detecting the tumour-associated epitope, TA-MUC1, as compared to antibodies HMFG-1 and 115D8.

Dian, D., Lenhard, M., Mayr, D. C., Heublein, S., Karsten, U. R., Goletz, S., Kühn, C., Wiest, I., Friese, K., Weissenbacher, T. M., et al. (2013) · PubMed · doi:10.14670/hh-28.239 · Cited by 21 · see citing works

Determination of MUC1 in sera of ovarian cancer patients and in sera of patients with benign changes of the ovaries with CA15-3, CA27.29, and PankoMab.

Jeschke, U., Wiest, I., Schumacher, A. L., et al. (2012) · PubMed · Cited by 21 · see citing works

Immunohistochemical expression of glycodelin in breast cancer correlates with estrogen-receptor alpha and progesterone-receptor A positivity.

Scholz, C., Tóth, B., Barthell, E., et al. (2009) · PubMed · doi:10.14670/hh-24.467 · Cited by 17 · see citing works

Subcellular localization of KL-6 mucin in colorectal carcinoma cell lines: Association with metastatic potential and cell morphology

Guo, Q., Tang, W., Inagaki, Y., et al. (2007) · Oncology Reports · doi:10.3892/or.17.5.1057 · Cited by 10 · see citing works

Distinct Cytoplasmic Expression of KL-6 Mucin in Chromophobe Renal Cell Carcinoma: A Comparative Immunohistochemical Study with Other Renal Epithelial Cell Tumors

Fukushima, M., Higuchi, K., Shimojo, H., et al. (2012) · ACTA HISTOCHEMICA ET CYTOCHEMICA · doi:10.1267/ahc.12020 · Cited by 4 · see citing works

Smart nanoparticles for cancer therapy

Sun, L., Liu, H., Ye, Y., Lei, Y., Islam, R., Tan, S., Tong, R., Miao, Y.-B., & Cai, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01642-x · Cited by 1,073 · see citing works

Fine specificity of the B-cell epitopes recognized in HIV-1 NEF by human sera

Tähtinen, M., Gombert, F. O., Hyytinen, E., et al. (1992) · Virology · doi:10.1016/0042-6822(92)90304-8 · Cited by 6 · see citing works

Induction of High Levels of Antibodies Recognizing the Neutralizing Epitope ELDKWA and the D- or K-Position-Mutated Epitopes by Candidate Epitope Vaccines against HIV-1

Xiao, Y. Q., Dong, X., & Chen, Y. (2000) · International Archives of Allergy and Immunology · doi:10.1159/000024411 · Cited by 7 · see citing works

Mapping of 10 epitopes on bovine herpesvirus type 1 glycoproteins gl and glll

Fitzpatrick, D. R., Redmondz, M. J., ATTAH‐POKU, S. K., et al. (1990) · Virology · doi:10.1016/0042-6822(90)90239-n · Cited by 34 · see citing works

Antigenicity and Predefined Specificities of the Multi-Epitope Vaccine in Candidate Consisting of Neutralizing Epitope and Mutated Epitopes Suggested a New Way against HIV-1 Mutation

Tian, H. (2001) · Immunobiology · doi:10.1078/0171-2985-00053 · Cited by 7 · see citing works

Identification of linear B cell epitopes on VP1 and VP2 proteins of Senecavirus A (SVA) using monoclonal antibodies

Fan, H., Zhu, H., Li, S., et al. (2020) · Veterinary Microbiology · doi:10.1016/j.vetmic.2020.108753 · Cited by 34 · see citing works